Abivax SA (AAVXF)
15.15
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Abivax Shareholders Equity (Quarterly): 216.67M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 216.67M |
| June 30, 2023 | 87.47M |
| June 30, 2023 | 87.47M |
| December 31, 2022 | 7.710M |
| June 30, 2022 | 6.351M |
| June 30, 2022 | 6.351M |
| December 31, 2021 | 29.36M |
| June 30, 2021 | 2.825M |
| June 30, 2021 | 2.825M |
| December 31, 2020 | 22.02M |
| June 30, 2020 | 10.80M |
| June 30, 2020 | 10.80M |
| December 31, 2019 | 20.83M |
| June 30, 2019 | 23.78M |
| Date | Value |
|---|---|
| June 30, 2019 | 23.78M |
| December 31, 2018 | 39.64M |
| June 30, 2018 | 47.50M |
| June 30, 2018 | 47.50M |
| December 31, 2017 | 57.80M |
| June 30, 2017 | 58.53M |
| June 30, 2017 | 58.53M |
| December 31, 2016 | 59.96M |
| June 30, 2016 | 69.94M |
| June 30, 2016 | 69.94M |
| December 31, 2015 | 78.43M |
| June 30, 2015 | 90.33M |
| June 30, 2015 | 90.33M |
| December 31, 2014 | 41.27M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.825M
Minimum
Jun 2021
216.67M
Maximum
Dec 2023
37.27M
Average
20.83M
Median
Dec 2019
Shareholders Equity (Quarterly) Benchmarks
| DBV Technologies SA | 111.65M |
| Cellectis SA | 84.70M |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | 75.11M |
| Innate Pharma SA | 57.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 361.53M |
| Total Liabilities (Quarterly) | 144.86M |